PT832241E - Mutantes de toxina a estreptococica e metodos de utilizacao - Google Patents
Mutantes de toxina a estreptococica e metodos de utilizacaoInfo
- Publication number
- PT832241E PT832241E PT96921589T PT96921589T PT832241E PT 832241 E PT832241 E PT 832241E PT 96921589 T PT96921589 T PT 96921589T PT 96921589 T PT96921589 T PT 96921589T PT 832241 E PT832241 E PT 832241E
- Authority
- PT
- Portugal
- Prior art keywords
- spe
- methods
- toxin
- vaccine
- toxins
- Prior art date
Links
- 239000003053 toxin Substances 0.000 title abstract 6
- 231100000765 toxin Toxicity 0.000 title abstract 6
- 108700012359 toxins Proteins 0.000 abstract 5
- 229960005486 vaccine Drugs 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100001160 nonlethal Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48026195A | 1995-06-07 | 1995-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT832241E true PT832241E (pt) | 2005-08-31 |
Family
ID=23907283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96921589T PT832241E (pt) | 1995-06-07 | 1996-06-07 | Mutantes de toxina a estreptococica e metodos de utilizacao |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6632441B2 (pt) |
| EP (2) | EP0832241B1 (pt) |
| JP (1) | JPH11514844A (pt) |
| KR (1) | KR100456594B1 (pt) |
| AT (1) | ATE291625T1 (pt) |
| AU (1) | AU723116B2 (pt) |
| CA (1) | CA2221480A1 (pt) |
| DE (1) | DE69634510T2 (pt) |
| DK (1) | DK0832241T3 (pt) |
| ES (1) | ES2239332T3 (pt) |
| PT (1) | PT832241E (pt) |
| WO (1) | WO1996040930A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW517061B (en) * | 1996-03-29 | 2003-01-11 | Pharmacia & Amp Upjohn Ab | Modified/chimeric superantigens and their use |
| US6774218B2 (en) | 1996-12-06 | 2004-08-10 | Regents Of The University Of Minnesota | Mutants of streptococcal toxin C and methods of use |
| WO1998024911A2 (en) * | 1996-12-06 | 1998-06-11 | Regents Of The University Of Minnesota | Mutants of streptococcal toxin a and methods of use |
| WO1998024910A2 (en) | 1996-12-06 | 1998-06-11 | Regents Of The University Of Minnesota | Mutants of streptococcal toxin c and methods of use |
| US6075119A (en) | 1997-04-07 | 2000-06-13 | The Rockefeller University | Peptides useful for reducing symptoms of toxic shock syndrome |
| US7087235B2 (en) * | 1997-06-25 | 2006-08-08 | The United States Of America As Represented By The Secretary Of The Army | Fusion protein of streptococcal pyrogenic exotoxins |
| US6872394B1 (en) | 1997-12-02 | 2005-03-29 | Idaho Research Foundation, Inc. | Non-toxic immune stimulating enterotoxin compositions |
| AU6059799A (en) * | 1998-10-07 | 2000-04-26 | Rockefeller University, The | Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| US20040236082A1 (en) * | 2001-04-13 | 2004-11-25 | Marshall Matthew J. | Modified staphylococcal enterotoxins and expression systems therefore |
| SE0102327D0 (sv) * | 2001-06-28 | 2001-06-28 | Active Biotech Ab | A novel engineered superantigen for human therapy |
| US20070178113A1 (en) * | 2005-11-22 | 2007-08-02 | Backstrom B T | Superantigen conjugate |
| CA2683748C (en) | 2007-04-13 | 2016-02-16 | The Board Of Regents Of The University Of Oklahoma | Mutants of cholesterol-dependent cytolysins and uses thereof |
| WO2015200833A2 (en) | 2014-06-27 | 2015-12-30 | Abbott Laboratories | COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2) |
| CA2968398A1 (en) | 2014-11-21 | 2016-05-26 | The Board Of Regents Of The University Of Oklahoma | Pneumolysin mutants and methods of use thereof |
| EP3411409A2 (en) | 2016-01-10 | 2018-12-12 | Neotx Therapeutics Ltd. | Immunopotentiator enhanced superantigen mediated cancer immunotherapy |
| CN114025791A (zh) | 2019-05-15 | 2022-02-08 | 尼奥克斯医疗有限公司 | 癌症治疗 |
| CN115484978A (zh) | 2020-03-05 | 2022-12-16 | 尼奥克斯医疗有限公司 | 使用免疫细胞治疗癌症的方法和组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4784948A (en) * | 1983-08-10 | 1988-11-15 | The Rockefeller University | Production of streptococcal m protein immunogens and molecular probes |
| US5336598A (en) | 1989-11-15 | 1994-08-09 | National Jewish Center For Immunology And Respiratory Medicine | Method for diagnosing a superantigen caused pathologial condition via assay of T-cells |
| US5298396A (en) | 1989-11-15 | 1994-03-29 | National Jewish Center For Immunology And Respiratory Medicine | Method for identifying T cells disease involved in autoimmune disease |
| WO1993014634A1 (en) | 1992-01-28 | 1993-08-05 | National Jewish Center For Immunology And Respiratory Medicine | Protective effects of mutated superantigens |
-
1996
- 1996-06-07 US US08/973,391 patent/US6632441B2/en not_active Expired - Fee Related
- 1996-06-07 WO PCT/US1996/010252 patent/WO1996040930A1/en active IP Right Grant
- 1996-06-07 PT PT96921589T patent/PT832241E/pt unknown
- 1996-06-07 DK DK96921589T patent/DK0832241T3/da active
- 1996-06-07 JP JP9502265A patent/JPH11514844A/ja not_active Ceased
- 1996-06-07 AT AT96921589T patent/ATE291625T1/de not_active IP Right Cessation
- 1996-06-07 ES ES96921589T patent/ES2239332T3/es not_active Expired - Lifetime
- 1996-06-07 EP EP96921589A patent/EP0832241B1/en not_active Expired - Lifetime
- 1996-06-07 AU AU62782/96A patent/AU723116B2/en not_active Ceased
- 1996-06-07 CA CA002221480A patent/CA2221480A1/en not_active Abandoned
- 1996-06-07 DE DE69634510T patent/DE69634510T2/de not_active Expired - Fee Related
- 1996-06-07 EP EP05075021A patent/EP1538208A3/en not_active Withdrawn
- 1996-06-07 KR KR1019970709192A patent/KR100456594B1/ko not_active IP Right Cessation
-
2003
- 2003-07-22 US US10/625,221 patent/US6870042B1/en not_active Expired - Fee Related
-
2005
- 2005-03-21 US US11/085,466 patent/US20060039925A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1538208A2 (en) | 2005-06-08 |
| WO1996040930A1 (en) | 1996-12-19 |
| JPH11514844A (ja) | 1999-12-21 |
| ES2239332T3 (es) | 2005-09-16 |
| US20020054887A1 (en) | 2002-05-09 |
| KR19990022750A (ko) | 1999-03-25 |
| EP1538208A3 (en) | 2007-05-23 |
| DE69634510D1 (de) | 2005-04-28 |
| AU6278296A (en) | 1996-12-30 |
| DE69634510T2 (de) | 2006-01-26 |
| US20060039925A1 (en) | 2006-02-23 |
| EP0832241A1 (en) | 1998-04-01 |
| KR100456594B1 (ko) | 2005-06-17 |
| US6632441B2 (en) | 2003-10-14 |
| CA2221480A1 (en) | 1996-12-19 |
| US6870042B1 (en) | 2005-03-22 |
| EP0832241B1 (en) | 2005-03-23 |
| ATE291625T1 (de) | 2005-04-15 |
| AU723116B2 (en) | 2000-08-17 |
| DK0832241T3 (da) | 2005-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT832241E (pt) | Mutantes de toxina a estreptococica e metodos de utilizacao | |
| EA200100565A1 (ru) | Новые стрептококковые антигены | |
| ATE314475T1 (de) | Rekombinantes pseudomonas exotoxin mit gesteigerter aktivität | |
| MXPA02001911A (es) | Anticuerpos ctla-4 humanos y sus usos. | |
| PT946730E (pt) | Mutantes de toxina estreptococica c e metodos de utilizacao | |
| ATE490311T1 (de) | Mutanten der alpha-amylase | |
| ATE337399T1 (de) | Zusammensetzungen zur immuntherapie und diagnose von tuberculosis | |
| ATE476495T1 (de) | Bazillus thuringiensis und dessen insektizide proteine | |
| PT866720E (pt) | Proteina ob para aumentar a massa do tecido mole | |
| WO1998024911A3 (en) | Mutants of streptococcal toxin a and methods of use | |
| DK0494294T3 (da) | Bakterielle stressproteiner | |
| DE69937965D1 (de) | Virulenzgene und deren proteine und verwendungen | |
| CA2282726A1 (fr) | Nouvelles utilisations de la sterilite male chez les plantes | |
| DK0647654T3 (da) | Anomere fluor-ribosylaminer | |
| EA200100701A1 (ru) | Белки наружной поверхности, их гены и их применение | |
| BR0007255A (pt) | Derivados carbamato de diaril 1,3,4-oxadiazolona | |
| AU1720497A (en) | Use of primers for universal fingerprint analysis | |
| FR2707492B1 (fr) | Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application. | |
| ATE150089T1 (de) | Bacillus thuringiensis p-2-toxingen, protein und damit in zusammenhang stehende insektizide zusammensetzungen | |
| BR9611904A (pt) | Dioxidos de ditiazol | |
| ES2183947T3 (es) | Mutantes que producen un potencializador de la actividad pesticida de un bacillus. | |
| IT1276454B1 (it) | Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico. | |
| RU93031380A (ru) | Биологический инсектицид для борьбы с чешуекрылыми насекомыми | |
| FR2705687B1 (fr) | Identification clonage et expression de l'enzyme malolactique. | |
| DE59914550D1 (de) | Synthetisches nukleinsäure-partikel |